Dr. Blevins’ main clinical interests are in the evaluation and management of patients with various disorders of the pituitary gland and hypothalamus. He has particular expertise with regards to Cushing’s syndrome and has edited a book on the subject. He also has extensive experience in treating patients with acromegaly, prolactinoma’s, other pituitary tumors, diabetes insipidus, and hypopituitarism. He has extensive experience in the management of patients with growth hormone deficiency. Dr. Blevins is medical director of the California Center for Pituitary Disorders at UCSF.
His current research interests involve diagnostic testing in patients with hypercortisolism. He is currently evaluating new ways to test for the presence of Cushing’s syndrome. He is also interested in clinical predictors of surgical and medical success with regards to the management of patients with different types of pituitary tumors. Some of this work involves collaboration with neuropathologists at UCSF. Dr. Blevins is also involved with industry sponsored trials to evaluate new pharmacologic therapies for patients with pituitary tumors.
Lewis S. Blevins Jr., MD
Professor of Clinical Medicine and Clinical Neurological Surgery
Medical Director, California Center for Pituitary Disorders at UCSF
Description
Presenter Bio:
Dr. Blevins’ main clinical interests are in the evaluation and management of patients with various disorders of the pituitary gland and hypothalamus. He has particular expertise with regards to Cushing’s syndrome and has edited a book on the subject. He also has extensive experience in treating patients with acromegaly, prolactinoma’s, other pituitary tumors, diabetes insipidus, and hypopituitarism. He has extensive experience in the management of patients with growth hormone deficiency. Dr. Blevins is medical director of the California Center for Pituitary Disorders at UCSF.
His current research interests involve diagnostic testing in patients with hypercortisolism. He is currently evaluating new ways to test for the presence of Cushing’s syndrome. He is also interested in clinical predictors of surgical and medical success with regards to the management of patients with different types of pituitary tumors. Some of this work involves collaboration with neuropathologists at UCSF. Dr. Blevins is also involved with industry sponsored trials to evaluate new pharmacologic therapies for patients with pituitary tumors.
